Larvol Delta - A-Postmarketing-Study-of-Lecanemab-for-the-Treatment-of-Participants-With-Alzheimer39s-Disease

Leqembi (lecanemab-irmb) - Biogen, Eisai

http://clinicaltrials.gov/ct2/show/NCT07821658

Sep 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next